Home·Stocks·TWST
Twist Bioscience Corporation Common Stock

TWST

XNAS

Twist Bioscience Corporation Common Stock

Basic Materials · Biological Products, (No Diagnostic Substances)

$65.30
-3.73 (-5.40%)
15-min delayed

Drag to pan · Scroll to zoom · Hover for OHLC

Snapshot
Loading metrics…
About Twist Bioscience Corporation Common Stock

Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

Employees
979
Country
US
IPO Date
2018-10-31
www.twistbioscience.com
COMMUNITY · $TWST0 theses
POST YOUR TAKE →
Analyst Ratings
Loading…
Financials
Loading SEC filings…
Insider Activity
Loading filings…
Related Stocks
Loading peers…

Data is 15-minute delayed, for informational purposes only. Not investment advice. Prices via Massive.com consolidated feed. Fundamentals via FinancialModelingPrep. News via Finnhub.

TWST Twist Bioscience Corporation Common Stock Stock — $65.30 -5.40% · AlgoThesis